Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device | Zendy

James S. Gammie | Zendy; Peter Wilson | Zendy; Krzysztof Bartuś | Zendy; Andrzej Gackowski | Zendy; Judy Hung | Zendy; Michael N. DʼAmbra | Zendy; Piotr Kołsut | Zendy; Gregory J. Bittle | Zendy; Piotr Szymański | Zendy; Jerzy Sadowski | Zendy; Bogusław Kapelak | Zendy; Agata Bilewska | Zendy; Mariusz Kuśmierczyk | Zendy; Mehrdad Ghoreishi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device

Author(s) -

James S. Gammie,

Peter Wilson,

Krzysztof Bartuś,

Andrzej Gackowski,

Judy Hung,

Michael N. DʼAmbra,

Piotr Kołsut,

Gregory J. Bittle,

Piotr Szymański,

Jerzy Sadowski,

Bogusław Kapelak,

Agata Bilewska,

Mariusz Kuśmierczyk,

Mehrdad Ghoreishi

Publication year - 2016

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.116.022010

Subject(s) - medicine , median sternotomy , mitral valve repair , thoracotomy , mitral regurgitation , ejection fraction , mitral valve , surgery , cardiology , cardiopulmonary bypass , heart disease , heart failure

Degenerative mitral valve (MV) disease is a common cause of severe mitral regurgitation (MR) and accounts for the majority of MV operations. Conventional MV surgery requires cardiopulmonary bypass, aortic cross-clamping, cardioplegia, and a thoracotomy or sternotomy and, therefore, is associated with significant disability, risks, and unpredictable rates of MV repair. Transesophageal echocardiography-guided beating-heart MV repair with expanded polytetrafluoroethylene cordal insertion has the potential to significantly reduce surgical morbidity. We report the first-in-human clinical experience with a novel preformed expanded polytetrafluoroethylene knot implantation device (Harpoon TSD-5) designed to treat degenerative MR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research